Dissection of the molecular basis for hypervirulence of an in vivo-selected phenotype of the widely disseminated M1T1 strain of group a streptococcus bacteria

Journal of Infectious Diseases

Volumn 201, Issue 6, 2010, Pages 855-865

  Kansal, Rita G ^a,b,d   Datta, Vivekanand ^b   Aziz, Ramy K ^a,c   Abdeltawab, Nourtan F ^a,b,d   Rowe, Sarah ^a,b   Kotb, Malak ^a,b,d  

^a Medical Services Research Group   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c CAIRO UNIVERSITY   (Egypt)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; GENE EXPRESSION; GENE MUTATION; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

ANIMALS; BACTERIAL PROTEINS; CYSTEINE ENDOPEPTIDASES; DEOXYRIBONUCLEASE I; EXOTOXINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MEMBRANE PROTEINS; MICE; MICE, INBRED CBA; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 77749271269     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651019     Document Type: Article

References (46)

1. Kotb M. Bacterial pyrogenic exotoxins as superaritigeris. Clin Microbiol Rev 1995;8:411-426.
2. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
3. Chhatwal GS, McMillan DJ. Uncovering the mysteries of invasive streptococcal diseases. Trends Mol Med 2005; 11:152-155.
4. Norrby-Teglund A, Kotb M. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 2000; 49:849-852.
5. Norrby-Teglund A, Low DE. Group A streptococcal toxic shock and necrotizing fasciitis. Curr Treat Options Infect Dis 2003;5:419-429.
6. Kansal RG, Aziz RK, Kotb M. Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions. J Infect Dis 2005; 191:2121-2129.
7. Kwinn LA, Khosravi A, Aziz RK, et al. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin S operon in invasive M1T1 group A Streptococcus. J Bacteriol 2007; 189: 1322-1329.
8. Buchanan JT, Simpson AJ, Aziz RK, et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extra-cellular traps. Curr Biol 2006; 16:396-400.
9. Walker MJ, Hollands A, Sanderson-Smith ML, et al. DNase Sda1 provides selection pressure for a switch to invasive group A Streptococcal infection. Nat Med 2007; 13:981-985.
10. Aziz RK, Pabst MJ, Jeng A, et al. Invasive M1T1 group A streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 2004;51:123-134.
11. Kazmi SU, Kansal R, Aziz RK, et al. Reciprocal, temporal expression of Spea and Speb by invasive M1T1 group A streptococcal isolates in vivo. Infect Immun 2001; 69:4988-4995.
12. Aziz RK, Kotb M. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 2008; 14:1511-1517.
13. Chatellier S, Ihendyane N, Kansal RG, et al. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68:3523-3534.
14. Aziz RK, Edwards RA Taylor WW, Low DE, McGeer A, Kotb M. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol 2005; 187:3311-3318.
15. Aziz RK, Ismail SA, Park HW, Kotb M. Post-proteomic identification of a novel phage-encoded streptodomase, Sda1, in invasive M1T1 Streptococcus pyogenes. Mol Microbiol 2004;54:184-197.
16. Ekelund K, Darenberg J, Norrby-Teglund A, et al. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 2005; 43: 3101-3109.
17. Rogers S, Commons R, Danchin MH, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A Streptococcus infections. J Infect Dis 2007; 195:1625-1633.
18. Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 2000; 68: 6362-6369.
19. Sumby P, Whitney AR, Graviss EA, Deleo FR, Musser JM. Genomewide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006; 2:e5.
20. Kreikemeyer B, McIver KS, Podbielski A. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol 2003; 11:224-232.
21. Federle MJ, McIver KS, Scott JR. A response regulator that represses transcription of several virulence operons in the group A Streptococcus. J Bacteriol 1999; 181:3649-3657.
22. Graham MR, Virtaneva K, Porcella SF, et al. Group A streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 2005; 166:455-465.
23. Miller AA, Engleberg NC, DiRita VJ. Repression of virulence genes by phosphorylation-dependent oligomerization of CsrR at target promoters in S. pyogenes. Mol Microbiol 2001; 40:976-990.
24. Framson PE, Nittayajarn A, Merry J, Youngman P, Rubens CE. New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol 1997; 63:3539-3547.
25. Aziz RK, Kansal R, Abdeltawab NF, et al. Susceptibility to severe streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun 2007;8:404-415.
26. Medina E, Goldmann O, Rohde M, Lengeling A, Chhatwal GS. Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis 2001; 184:846-852.
27. Treviño J, Perez N, Ramirez-Pena E, et al. CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun 2009; 77:3141-3149.
28. Kansal RG, Nizet V, Jeng A, Chuang WJ, Kotb M. Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J Infect Dis 2003; 187:398-407.
29. Sun H, Ringdahl U, Homeister JW, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305:1283-1286.
30. Gryllos I, Levin JC, Wessels MR. The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+. Proc Natl Acad Sci U S A 2003; 100:4227-4232.
31. Engleberg NC, Heath A, Vardaman K, DiRita VJ. Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun 2004; 72:623-628.
32. Gao J, Gusa AA, Scott JR, Churchward G. Binding of the global response regulator protein CovR to the sag promoter of Streptococcus pyogenes reveals a new mode of CovR-DNA interaction. J Biol Chem 2005; 280:38948-38956.
33. Nizet V, Beall B, Bast DJ, et al. Genetic locus for streptolysin S production by group A Streptococcus. Infect Immun 2000; 68:4245-4254.
34. Datta V, Myskowski SM, Kwinn LA, et al. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol 2005;56:681-695.
35. Gryllos I, Tran-Winkler HJ, Cheng MF, et al. Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sei U S A 2008; 105:16755-16760.
36. Zinkemagel AS, Timmer AM, Pence MA, et al. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 2008;4:170-178.
37. Edwards AM, Manetti AG, Falugi F, et al. Scavenger receptor gp340 aggregates group A streptococci by binding pili. Mol Microbiol 2008; 68:1378-1394.
38. Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B Streptococcus paradigm. J Infect Dis 2009; 199:108-115.
39. Shelburne SA, Davenport MT, Keith DB, Musser JM. The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol 2008; 16:318-325.
40. Shelburne SA, 3rd, Keith DB, Davenport MT, Horstmann N, Brennan RG, Musser JM. Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 2008;69:436-452.
41. Shelburne SA, 3rd, Keith D, Horstmann N, et al. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A 2008; 105:1698-1703.
42. Graham MR, Smoot LM, Migliaccio CA, et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A 2002;99:13855-13860.
43. Heath A, DiRita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 1999; 67:5298-5305.
44. Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 2001; 183:1043-1054.
45. Dalton TL, Scott JR. CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J Bacteriol 2004; 186:3928-3937.
46. Gao R, Stock AM. Biological insights from structures of two-component proteins. Annu Rev Microbiol 2009; 63:133-154.